Constriction of the fetal ductus arteriosus during prenatal betamethasone therapy

• Type: Article in International Scientific Journal
• Date: 1995

Authors

Azancot Benisty, A (Author) Other; Benifla, JL (Author) Other; matias, a (Author) FMUP; De Crepy, A (Author) Other; Madelenat, P (Author) Other

Journal

Title: Obstetrics and Gynecology

Vol. 85

Pages: 874-876

ISSN: 0029-7844

Publisher: Wolters Kluwer Health

Indexing

Scopus - 33 Citations

Other information

Authenticus ID: P-008-PNC

DOI: 10.1016/0029-7844(94)00445-j

Abstract (EN): Background: Constriction of the fetal ductus arteriosus occurs with maternal indomethacin treatment and has been suggested with corticosteroid therapy as well. Case: Fetal ductal constriction was diagnosed by Doppler echocardiography at 29 weeks' gestation after a third and fourth course of betamethasone was administered to a pregnant woman with placenta previa. Doppler echocardiography showed a patent ductus arteriosus 3 days after the treatment. Conclusion: The risk-benefit ratio of betamethasone should be assessed by large-scale studies when repeated courses or chronic maternal administration of betamethasone are required.

Language: English

Type (Professor's evaluation): Scientific